| (KRW) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 155.71B | — |
| Operating expense | — | — |
| Net income | -17.89B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 302440.KS returned -22.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -22.2% |
| 1 year | -22.0% |
| 5 years | -88.0% |
| All-time high | ₩313,500 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₩1,000 in 302440.KS would be worth today ›No. SK bioscience Co.,Ltd. has not paid a dividend in the past 12 months.
SK bioscience Co.,Ltd. is part of the Healthcare sector.
SK bioscience Co.,Ltd. has a market cap of 2.94T KRW, based on the latest quote.
SK bioscience Co.,Ltd. is expected to report earnings around Oct 26, 2026. That date is an estimate and has not been confirmed by the company.
